Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s735. https://doi.org/10.25251/078a3s70